I
260.71
1.33 (0.51%)
| Penutupan Terdahulu | 259.38 |
| Buka | 258.75 |
| Jumlah Dagangan | 465,391 |
| Purata Dagangan (3B) | 795,118 |
| Modal Pasaran | 18,308,644,864 |
| Harga / Pendapatan (P/E TTM) | 45.03 |
| Harga / Pendapatan (P/E Ke hadapan) | 62.50 |
| Harga / Jualan (P/S) | 9.30 |
| Harga / Buku (P/B) | 15.11 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 8 May 2025 |
| Margin Keuntungan | 20.19% |
| Margin Operasi (TTM) | 16.03% |
| EPS Cair (TTM) | 5.79 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 17.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -2.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 118.37% |
| Nisbah Semasa (MRQ) | 3.58 |
| Aliran Tunai Operasi (OCF TTM) | 430.30 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 155.28 M |
| Pulangan Atas Aset (ROA TTM) | 6.80% |
| Pulangan Atas Ekuiti (ROE TTM) | 43.03% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | Insulet Corporation | Menaik | Menaik |
AISkor Stockmoo
2.4
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 4.0 |
| Purata | 2.38 |
|
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 0.38% |
| % Dimiliki oleh Institusi | 102.93% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 380.00 (Citigroup, 45.76%) | Beli |
| Median | 340.00 (30.41%) | |
| Rendah | 266.00 (Barclays, 2.03%) | Pegang |
| Purata | 332.00 (27.35%) | |
| Jumlah | 4 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 292.32 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 22 May 2025 | 380.00 (45.76%) | Beli | 324.50 |
| Wolfe Research | 13 May 2025 | 350.00 (34.25%) | Beli | 314.46 |
| Oppenheimer | 09 May 2025 | 324.00 (24.28%) | Beli | 310.67 |
| Barclays | 30 Apr 2025 | 266.00 (2.03%) | Pegang | 252.29 |
| RBC Capital | 06 Mar 2025 | 340.00 (30.41%) | Beli | 259.67 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |